Stenotrophomonas (Xanthomonas) maltophilia as an emerging opportunistic pathogen in association with HIV infection: A 10-year surveillance study

Infection

Volumn 31, Issue 3, 2003, Pages 155-161

  Calza, L ^a   Manfredi, R ^a   Chiodo, F ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; AZTREONAM; BETA LACTAM; IMIPENEM;

ADULT; ANTIBIOTIC RESISTANCE; BACTEREMIA; BACTERIAL INFECTION; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; COMPARATIVE STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; EPIDEMIOLOGICAL DATA; EVALUATION; FEMALE; HEALTH CENTER; HEALTH SURVEY; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; LABORATORY TEST; LIVER ABSCESS; LYMPHADENITIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PATHOGENESIS; PATIENT REFERRAL; PHARYNGITIS; RESPIRATORY TRACT INFECTION; RETROSPECTIVE STUDY; REVIEW; RISK FACTOR; SALMONELLA; SALMONELLOSIS; SEPSIS; STENOTROPHOMONAS MALTOPHILIA; URINARY TRACT INFECTION;

EID: 0038115417     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15010-003-3113-6     Document Type: Review

References (47)

1. Muder RR, Harris AP, Muller S, Edmond M, Chow JW, Papadakis K, Wagener MW, Bodey GP, Steckelberg JM: Bacteremia due to Stenotrophomonas (Xanthomonas) maltophilia: a prospective, multicenter study of 91 episodes. Clin Infect Dis 1996; 22: 508-512.
2. Victor MA, Arpi M, Bruun B, Jonsson V, Hansen MM: Xanthomonas maltophilia bacteremia in immunocompromised hematological patients. Scand J Infect Dis 1994; 26: 163-170.
3. Micozzi A, Venditti M, Monaco M, Friedrich A, Taglietti F, Santilli S, Martino P: Bacteremia due to Stenotrophomonas maltophilia in patients with hematologic malignancies. Clin Infect Dis 2000; 31: 705-711.
4. Hancock REW: Resistance mechanisms in Pseudomonas aeruginosa and other nonfermenative gram-negative bacteria. Clin Infect Dis 1998; 27(suppl 1): 93-99.
5. Calza L, Manfredi R, Marinacci G, Fortunato L, Chiodo F: Liver abscess caused by Stenotrophomonas (Xanthomonas) maltophilia in a patient with AIDS. AIDS 2001; 15: 2465-2467.
6. Nelson MR, Shanson DC, Barter GJ, Hawkins DA, Gazzard BG: Pseudomonas septicemia associated with HIV. AIDS 1991; 5: 761-763.
7. Andiman WA, Mezger J, Shapiro E: Invasive bacterial infections in children born to women infected with human immunodeficiency virus. J Pediatr 1994; 124: 846-852.
8. Ruiz Contreras J, Ramos JT, Hernandez 5ampelayo T, Gurbindo MD, Garcia de Jose M, De Miguel MJ, Cilleruelo MJ, Mellado MJ: Sepsis in children with human immunodeficiency virus infection. Pediatr Infect Dis J 1995; 14: 522-526.
9. Flores G, Stavola JJ, Noel GJ: Bacteremia due to Pseudomonas aeruginosa in children with AIDS. Clin Infect Dis 1993; 16: 706-708.
10. Berger BJ, Hussain F, Roistacher K: Bacterial infections in HIV-infected patients. Infect Dis Clin North Am 1994; 8: 449-465.
11. Fichtenbaum CJ, Dunagan WC, Powderly WG: Bacteremia in hospitalized patients infected with the human immunodeficiency virus: a case-control study of risk factors and outcome. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 8: 51-57.
12. Kielhofner M, Atmar RL, Hamill RJ, Musher DM: Life-threatening Pseudomonas aeruginosa infection in patients with human immunodeficiency virus infection. Clin Infect Dis 1992; 14: 403-411.
13. Shepp DH, Tang IT, Ramundo MB, Kaplan MK: Serious Pseudomonas aeruginosa infection in AIDS. J Acquir Immune Defic Syndr 1994; 7: 823-831.
14. Fish DN, Danziger LH: Neglected pathogens: bacterial infections in persons with human immunodeficiency virus infection. A review of the literature (Part 1 and 2). Pharmacotherapy 1993; 13: 415-439, 543-563.
15. Vugia DJ, Kiehlbauch JA, Yeboue K, N'Gbichi JM, Lacina D, Maran M, Gondo M, Kouadio K, Kadio A, Lucas SB: Pathogens and predictors of fatal septicemia associated with human immunodeficiency virus infection in Ivory Coast, West Africa. J Infect Dis 1993; 168: 564-570.
16. Roilides E, Marshall D, Venzon D, Butler K, Husson R, Pizza PA: Bacterial infections in human immunodeficiency virus type 1-infected children. The impact of central venous catheters and antiretroviral agents. Pediatr Infect Dis J 1991; 10: 813-819.
17. Hirschtick RE, Glassroth J, Jordan MC, Wilcosky TC, Wallace JM, Kvale PA, Markowitz N, Rosen MJ, Mangura BT, Hopewell PC: Bacterial pneumonia in persons infected with the human immunodeficiency virus. N Engl J Med 1995; 333: 845-851.
18. Hambleton J, Aragon T, Modin G, Northfelt DW, Sande MA: Outcome for hospitalized patients with fever and neutropenia who are infected with the human immunodeficiency virus. Clin Infect Dis 1995; 20: 363-371.
19. Miller RF, Foley NM, Kessel D, Jeffrey AA: Community-acquired lobar pneumonia in patients with HIV infection and AIDS.Thorax 1994; 49: 367-368.
20. Tumbarello M, Tacconelli E, Caponera S, Cauda R, Ortona L: The impact of bacteraemia on HIV infection. Nine years experience in a large Italian university hospital. J Infect 1995; 31: 123-131.
21. Goetz AM, Squier C, Wagener MM, Muder RR: Nosocomial infections in the human immunodeficiency virus-infected patient: a two-year survey. Am J Infect Control 1994; 22: 334-339.
22. Schlamm HT, Yancovitz SR: Haemophilus influenzae pneumonia in young adults with AIDS, ARC, or at risk for AIDS. Am J Med 1989; 86: 11-14.
23. Sperber SJ, Schleupner CJ: Salmonellosis during infection with human immunodeficiency virus. Rev Infect Dis 1987; 9: 925-934.
24. Sattler CA, Mason EO, Kaplan SL: Nonrespiratory Stenotrophomonas maltophilia infection at a children's hospital. Clin infect Dis 2000; 31: 1321-1330.
25. Gutierrez Rodero F, Masia MdM, Cortes J, Ortiz de la Tabla V, Mainar V, Vilar A: Endocarditis caused by Stenotrophomonas maltophilia: case report and review. Clin Infect Dis 1996; 23: 1261-1265.
26. Aydin K, Koksal I, Kaygusuz S, Kaklikkaya I, Caylan R, Ozdemir R: Endocarditis caused by Stenotrophomonas maltophilia. Scand J Infect Dis 2000; 32: 427-430.
27. Schaumann R, Stein K, Eckhardt C, Ackermann G, Rodloff AC: Infections caused by Stenotrophomonas maltophilia. A prospective study. Infection 2001; 29: 205-208.
28. Spencer RC: The emergence of epidemic, multiple-antibiotic-resistant Stenotrophomonas (Xanthomonas) maltophilia and Burkholderia (Pseudomonas) cepacia. J Hosp Infect 1995; 30 (suppl): 453-464.
29. Roilides E, Butler KM, Husson RN, Mueller BU, Lewis LL, Pizzo PA: Pseudomonas infections in children with human immunodeficiency virus infection. Pediatr Infect Dis J 1992; 11: 547-553.
30. Heath T, Currie B: Nosocomial and community-acquired Xanthomonas maltophilia infection in tropical Australia. J Hosp Infect 1995; 30: 309-313.
31. VanCouwenberghe CJ, Farver TB, Cohen SH: Risk factors associated with isolation of Stenotrophomonas (Xanthomonas) maltophilia in clinical specimens. Infect Control Hosp Epidemiol 1997; 18: 316-321.
32. Laing FP, Ramotar K, Read RR, Alfieri N, Kureishi A, Henderson EA, Louie TJ: Molecular epidemiology of Xanthomonas maltophilia colonization and infection in the hospital environment. J Clin Microbiol 1995; 33: 513-518.
33. McDonald GR, Pernenkil R: Community-acquired Xanthomonas maltophilia pyelonephritis. South Med J 1993; 86: 967-968.
34. Nguyen MH, Muder RR: Meningitis due to Xanthomonas maltophilia: case report and review. Clin Infect Dis 1994; 19: 325-326.
35. Yao JD, Conly JM, Krajden M: Molecular typing of Stenotrophomonas (Xanthomonas) maltophilia by DNA macrorestriction analysis and random amplified polymorphic DNA analysis. J Clin Microbiol 1995; 33: 2195-2198.
36. Vartivarian S, Anaissie E, Bodey G, Sprigg H, Rolston K: A changing pattern of susceptibility of Xanthomonas maltophilia to antimicrobial agents: implications for therapy. Antimicrob Agents Chemother 1994; 38: 624-627.
37. Franzetti F, Cernuschi M, Esposito R, Moroni M: Pseudomonas infections in patients with AIDS and AIDS-related complex. J Intern Med 1992; 231: 437-443.
38. Bernard E, Carles M, Pradier C, Ozouf N, Dellamonica P: Septicémies communautaires et nosocomiales chez le patient infecté par le virus de l'immunodéficience humaine. Presse Med 1996; 25: 746-750.
39. Manfredi R, Nanetti A, Ferri M, Coronado OV, Mastroianni A, Chiodo F: Profile and trend of antimicrobial resistance of non-opportunistic bacterial pathogens isolated from patients with HIV infection. J Antimicrob Chemother 1996; 38: 910-913.
40. Ruga E, Giaquinto C, Cozzani S, Giacomelli A, Pagliaro A, Mazza A, De Manzini A, Laverda AM, D'Elia R: The use of antibiotics in the treatment and prevention of infection in HIV-infected children. Acta Paediatr 1994; (suppl 400): 70-72.
41. Chow AW, Wong J, Bartlett KH: Synergistic interactions of ciprofloxacin and extended-spectrum beta-lactams or aminoglycosides against multiple drug-resistant Pseudomonas maltophilia. Antimicrob Agents Chemother 1988; 6: 782-784.
42. Elting LS, Khardori N, Bodey GP, Fainstein V: Nosocomial infection caused by Xanthomonas maltophilia: a case-control study of predisposing factors. Infect Control Hosp Epidemiol 1990; 11: 134-138.
43. del Toro MD, Rodriguez-Bano J, Herrero M, Rivero A, Garcia-Ordonez MA, Corzo J, Perez-Cano R: Clinical epidemiology of Stenotrophomonas maltophilia colonization and infection: a multicenter study. Medicine (Baltimore) 2002; 81: 228-239.
44. Denton M, Kerr KG: Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia. Clin Microbiol Rev 1998; 11: 57-80.
45. Maningo E, Watanakunakorn C: Xanthomonas maltophilia and Pseudomonas cepacia in lower respiratory tracts of patients in critical care units. J Infect 1995; 31: 89-92.
46. Fichtenbaum CJ, Woeltje KF, Powderly WG: Serious Pseudomonas aeruginosa infections in patients infected with human immunodeficiency virus: a case-control study. Clin Infect Dis 1994; 19: 417-422.
47. Baron AD, Hollander H: Pseudomonas aeruginosa bronchopulmonary infection in late human immunodeficiency virus disease. Am Rev Respir Dis 1993; 148: 992-996.